Nurse specialist posts were the focus of a recent House of Lords debate in which the government was asked ‘what they can and will do to prevent primary care trusts and hospital trusts reducing spending on specialist nursing ser vices in the treatment and support of patients with long-term conditions’. While the focus was on long-term conditions, similar arguments could be applied to tissue viability specialist ser vices. However, this was not mentioned which may be because tissue viability is not disease specific, or perhaps because the specialty lacks powerful champions in the form of medical consultants.
